62135-496 : Griseofulvin Microsize Microsize 500 mg Oral Tablet
NDC: | 62135-496 |
Labeler: | Chartwell Rx, LLC. |
Product Type: | Human Prescription Drug |
Drug Name: | Griseofulvin Microsize |
Dosage Form: | Oral Tablet |
Application #: | ANDA060569 |
Rev. Date: |
NDC Package Codes:
- 62135-496-01: 100 TABLET IN 1 BOTTLE (62135‑496‑01)
- 62135-496-30: 30 TABLET IN 1 BOTTLE (62135‑496‑30)
Active Ingredients:
- Griseofulvin
Dosage Strength:
- 500 mg
Pharmaceutical Classes:
- Decreased Mitosis [PE]
- Microtubule Inhibition [PE]
- Tubulin Inhibiting Agent [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 62135-495Next: 62135-497 >
Related Discussions:
Griseofulvin Side Effects
The day after I started taking Griseofulvin for fungal infection of the nails, I had a sore throat and thick green phleg... 1 reply
The day after I started taking Griseofulvin for fungal infection of the nails, I had a sore throat and thick green phleg... 1 reply
MEDOFULVIN 125mg griseofulvin BP 125mg
hi, my daughter has take 4 tablets once, i have heared after 3 hours she take that tablet, when i take her to the doctor... 1 reply
hi, my daughter has take 4 tablets once, i have heared after 3 hours she take that tablet, when i take her to the doctor... 1 reply
griseofulvin ingredients
Please provide me a list of ingredients that make up the drug griseofulvin...
Please provide me a list of ingredients that make up the drug griseofulvin...
Griseofulvin drug interactions
What types of medicine should you not take while taking this medicine?...
What types of medicine should you not take while taking this medicine?...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.